Target intelligence / Profile preview

U6 small nuclear RNA 17, pseudogene (RNU6-17P)

Target
RNU6-17P
Molecular classification
Pseudogene, Small nuclear RNA pseudogene, Noncoding RNA
01

Overview

RNU6-17P, also known as "RNA, U6 small nuclear 17, pseudogene," is a noncoding RNA gene classified as a pseudogene of the U6 small nuclear RNA family. U6 small nuclear RNA (snRNA) plays a crucial role in mRNA splicing as a component of the spliceosome, but as a pseudogene, RNU6-17P does not encode functional RNA and is not transcribed as a biologically active molecule[5][1]. U6 snRNA pseudogenes are generated by retrotransposition processes and are present as non-functional genomic relics, lacking roles in splicing or other cellular mechanisms[5]. There is no evidence that RNU6-17P serves as a therapeutic target, nor is it associated with drug interactions, biomarkers, or safety concerns. Pseudogenes like RNU6-17P may be used as markers of retrotransposition activity in comparative genomics studies[5]. The "is_incorrect" flag is marked true because this entry refers to a pseudogene rather than a functional therapeutic target, receptor, or conventional drug target.

Other names
RNU6-17RNU6-17PRNA, U6 small nuclear 17, pseudogene
02

Mechanism of action

None

03

Biological functions

None (no direct function; pseudogenes are typically non-functional copies)
04

Disease associations

Other (no direct disease role known; pseudogenes occasionally serve as genomic markers or have regulatory roles, but none are characterized for RNU6-17P specifically[5])
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on U6 small nuclear RNA 17, pseudogene (RNU6-17P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U6 small nuclear RNA 17, pseudogene (RNU6-17P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call